Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2018	Mar. 31, 2017
ASSETS
Cash and cash equivalents	$ 9,928	$ 9,429
Accounts receivable, net of allowance for doubtful accounts of $215 and $114 as of March 31, 2018 and March 31, 2017, respectively	6,605	7,042
Restricted cash	28	34
Prepaid expenses and other current assets	1,542	1,553
Total current assets	18,103	18,058
Property and equipment, net	90	85
Capitalized software development costs, net	2,994	2,341
Goodwill	15,458	14,448
Other intangibles, net	3,952	5,860
Other assets	1,467	1,599
Total assets	42,064	42,391
Current liabilities
Credit facility	12,128	11,861
Accounts payable	2,371	2,478
Accrued payroll and related liabilities	1,986	1,729
Other accrued liabilities	2,239	2,042
Deferred revenue	9,487	10,070
Income tax payable	48	23
COFACE loan		174
Total current liabilities	28,259	28,377
Long-term deferred revenue	84	10
Convertible note, net of debt discount	7,475	7,599
Other long-term liabilities	1,306	1,306
Total liabilities	37,124	37,292
Commitments and contingencies (Notes 7 and 8):
Stockholders’ equity:
Common stock, $0.0001 par value: Authorized: 35,000 shares at March 31, 2018 and 2017; Issued: 15,050 and 12,223 shares at March 31, 2018 and 2017, respectively; Outstanding: 14,905 and 12,078 shares at March 31, 2018 and 2017, respectively	7	5
Additional paid-in capital	325,942	317,367
Treasury stock at cost – 145 at March 31, 2018 and 2017	(472)	(472)
Accumulated deficit	(321,697)	(311,749)
Accumulated other comprehensive income (loss)	1,160	(52)
Total stockholders’ equity	4,940	5,099
Total liabilities and stockholders’ equity	$ 42,064	$ 42,391